Formulation Development

Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing

When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.

Why Emerging Drug Developers Can't Afford To Delay Analytical Development

Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.

Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk

Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.

How Peptides Became Cornerstones Of Modern Medicine

Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.

Spray Dried Biologics For Pulmonary Dosage Forms

Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

Mammalian Expression

See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

Integrated Stability Workflows That Reduce Manual Data Handling

Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.

Simplify And Streamline Method Development With In Silico Modeling

Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

Accelerated Yield Optimization Of Affinity Capture

High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.

Integrated Drug Discovery: Hit To PCC In 16 Months

Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.